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Introduction
Cystic fibrosis is the most common fatal inherited disease in people of European descent [1] . It is characterized by repeated bouts of infection and inflammation in the airways [2] . The lungs of children with cystic fibrosis are initially infected with Staphylococcus aureus and eventually with life threatening Pseudomonas aeruginosa [3] . To combat infections, neutrophils swarm into the airways and attempt to phagocytose bacteria. They also release antimicrobial proteins and eject extracellular traps [4] . The most abundant protein they release is calprotectin [5] . Formally known as the cystic fibrosis antigen, calprotectin is a heterodimer of S100A8 and S100A9 [6] . Recently, calprotectin was shown to be a critical factor in innate immunity because it can prevent bacterial growth by chelating Mn and Zn ions [7] . Severe Ϯ infections occur in the airways of patients with cystic fibrosis despite the presence of high concentrations of calprotectin [8] . This incongruity suggests that calprotectin is compromised in its ability to bind these metals so that bacteria are free to sequester them and grow.
The affinity that calprotectin has for metals may be weakened in cystic fibrosis by the oxidative insult that occurs when neutrophils try to kill bacteria. In their frustrated attempts to engulf bacteria, neutrophils use their NADPH oxidase to generate large amounts of superoxide, which they convert to chlorine bleach using the enzyme myeloperoxidase [9] . Substantial chlorine bleach or hypochlorous acid is formed in the epithelial lining fluid of children with cystic fibrosis, especially those infected with P aeruginosa [10] . Hypochlorous acid oxidizes methionine and cysteine residues on S100A8 and S100A9 [11] . Whether calprotectin is oxidized during infections in children with cystic fibrosis and no longer binds metals avidly has yet to be explored. Consequently, our aims in this investigation were to determine whether nutritional immunity afforded by the metal chelating properties of calprotectin is affected by hypochlorous acid and assess the extent to which calprotectin is oxidized in the airways of children with cystic fibrosis.
Materials and Methods

Materials
Staphylococcus aureus strain 502a (ATCC 27127) was attained from the New Zealand Communicable Disease Centre (Porirua, New Zealand). Pseudomonas aeruginosa was a clinical isolate of unknown origin. Hypochlorous acid (İ 292 = 350 M -1 .cm -1 at pH 12 [12] ) was purchased as commercial chlorine bleach from Household and Body Care (Auckland, New Zealand) . The N-terminal S100A8 tryptic peptide, MLTELEK, was custom synthesized by Genscript (Piscataway, NJ, USA). Myeloperoxidase (İ 430 = 89000 M -1 .cm -1 per heme, [13] ) was purchased from Planta (Austria). Myeloperoxidase inhibitors TX1 and HX1 were from Dr Eva-Lottie Lindstedt, AstraZeneca, Mölndal, Sweden. Hydrogen peroxide (İ 240 = 43.6 M -1 .cm -1 , [14] ) was from LabServ supplied by BioLab (Victoria, Australia). Trypticase soy broth was purchased from Sigma-Aldrich (St Louis, MO, USA). Chelex® 100 Resin was from Bio-Rad Laboratories (Hercules, CA, USA). All other chemicals were of analytical grade. Blood was obtained from healthy human volunteers with informed consent, and with ethical approval from the Canterbury Southern Ethics Committee.
Bacterial growth assay S. aureus and P. aeruginosa were cultured overnight in trypticase soy broth and diluted 1/50 or 1/25, respectively, into fresh broth and cultured for a further 100 minutes. Exponential phase bacteria were then diluted 1/20 into chelex-treated trypticase soy broth supplemented with 100 ȝM CaCl 2 , 5 ȝM FeSO 4 and 1 mM MgCl 2 . Bacterial growth was monitored at A 600 over 6 hours in the presence or absence of calprotectin (100 ȝg/mL), oxidized calprotectin (treated with hypochlorous acid), or additional MnCl 2 (5 ȝM) and Zn(C 2 H 3 O 2 ) 2 (5 ȝM). Further experiments were conducted in which the oxidized calprotectin was incubated with or without 10 mM DTT for 30 minutes at 37 °C prior to the assay. Treated calprotectin was also separated by SDS-PAGE in the absence or presence of 100 mM DTT and stained with Coomassie Blue [15] or transferred onto PVDF membranes for western blotting. Blots were probed with rabbit monoclonal antibodies to S100A8 [EPR3554] (1:15000) or mouse monoclonal antibodies to S100A9 [47-8D3] (1:1500) (Abcam supplied by Sapphire Bioscience Pty. Ltd., Redfern, Australia).
Study population
ϯ Eighteen children with a mean age of 3.2±2.1 years who had an established diagnosis of cystic fibrosis and who were taking part in the Australian Respiratory Early Surveillance Team for Cystic Fibrosis (AREST CF) program conducted by Princess Margaret Hospital (Perth, WA, Australia) were studied. This program involves an annual assessment that includes clinical evaluation and measurement of lung function and bronchoalveolar lavage for assessing pulmonary inflammation and infection. Additional information about the AREST CF program is available at telethonkids.org.au/arest-cf/. The surveillance program was approved by the local ethics committee and parents consented to each aspect of the program separately. Bronchoalveolar lavage fluid (BALF) was obtained as described previously [10] . Trypsin (50:1 substrate:trypsin weight ratio) was added to the BALF samples and incubated at 37 °C overnight for subsequent LC/MS analysis. Disease control subjects were children without cystic fibrosis who underwent bronchoalveolar lavage for assessment of persistent respiratory symptoms, including stridor, chronic cough, or recurrent pneumonia.
Preparation of S. aureus for phagocytosis experiments
S. aureus was cultured overnight in trypticase soy broth, harvested by centrifugation, washed and resuspended in HBSS (10 mM phosphate buffer, pH 7.4, containing 140 mM NaCl, 0.5 mM MgCl 2 , 1 mM CaCl 2 and 1 mg/mL glucose). S. aureus cell density was measured spectrophotometrically at 550 nm and bacterial cell numbers were calculated using a standard curve based on colony forming unit counts. All bacteria were opsonized with 10% autologous human serum and slowly rotated end-over-end for 20 minutes at 37 °C immediately before addition to neutrophils.
Isolation of human neutrophils
Neutrophils were isolated from heparinized peripheral blood of healthy adult donors under sterile conditions by Ficoll/Hypaque centrifugation, dextran sedimentation, and hypotonic lysis [16] .
Purification of calprotectin from human neutrophils
Calprotectin was purified from the cytosol of human neutrophils obtained by nitrogen cavitation using a previously described method [17] with Coomassie Blue-staining of reducing SDS-PAGE gels indicating the purity of calprotectin was 93%.
Determination of calprotectin peptides susceptible to oxidation
Calprotectin (40 ȝM) was treated with hypochlorous acid (0-200 ȝM) in PBS with constant mixing on a vortex and incubated at 37 °C for 10 minutes. Trypsin was added to all samples at a 50:1 substrate:trypsin weight ratio and incubated at 37 °C overnight before being analyzed by either MALDI TOF MS or LC/MS. Samples for MALDI TOF MS analysis were diluted 1 in 5 with matrix (10 mg per mL alpha cyano 4 hydroxycinnamic acid dissolved in 65% (v/v) aqueous acetonitrile containing 0.1% (v/v) trifluoroacetic acid and 10 mM ammonium dihydrogen phosphate). An aliquot of 0.8 ȝL was then spotted onto a matrixassisted laser desorption/ionisation (MALDI) sample plate (Opti-TOF 384 well plate, AB Sciex, MA, USA) and air dried. Samples were analyzed on a 4800 MALDI tandem Time-of-Flight Analyzer (MALDI TOF/TOF, AB Sciex, MA, USA). All MS spectra were acquired in linear, positive-ion mode with 1200 laser pulses per sample spot. The mass range between 1000 and 25000 was calibrated on a 5 peptide/protein calibration mix. Raw MALDI data were processed (baseline correction, noise removal and Gaussian smoothing) using Data ExplorerTM Software Version 4 (Applied Biosystems, CA, USA). Precursor ions of interest of each sample spot were selected for tandem mass spectrometry (MS/MS) collision-induced dissociation analysis. Collision-induced dissociation spectra were acquired with 2000-4000 laser pulses per selected precursor using the 2 kV mode and air as the collision gas at a pressure of 1*E-6 torr. Samples for LC/MS analysis were analyzed using a Thermo Finnigan LCQ Deca XP plus ion ϰ trap mass spectrometer or a Thermo Scientific Velos Pro ion trap mass spectrometer coupled to a Thermo Finnigan Surveyor HPLC system with a 50 ȝL injection loop (Thermo Finnigan, San Jose, CA, USA). A Thermo Hypercarb column (100 mm x 2.1 mm) (Thermo Finnigan, San Jose, CA, USA) was used for chromatographic separation using 100% water (0.1% formic acid) as Solvent A and 100% acetonitrile (0.1% formic acid) as Solvent B for positive ion monitoring experiments. Data were analyzed using Thermo Xcalibur Qual Browser 2.1 SP1 programs (Thermo Fisher Scientific Inc., Waltham, MA, USA). The relative abundance of each peptide was standardized based on the sum peak height (MALDI TOF MS analysis) or sum product ion scan peak area (LC/MS analysis) of peptides in that run that did not significantly change in abundance over all of the experiments (ALNSIIDVYHK, GNFHAVYR, LGHPDTLNQ-GEFK and DLQNFLK).
Mass spectrometry analysis of MLTELEK species
Peptide and digested protein samples were analyzed by LC/MS using a Thermo Finnigan LCQ Deca XP plus ion trap mass spectrometer or a Thermo Scientific Velos Pro ion trap mass spectrometer coupled to a Thermo Finnigan Surveyor HPLC system with a 50 ȝL injection loop (Thermo Finnigan, San Jose, CA, USA). Samples were stored on the autosampler tray at 5 °C. A Phenomenex Gemini 5 ȝ column (150 x 2.0 mm) (Phenomenex, North Shore City, NZ) or a Thermo Hypercarb column (100 mm x 2.1 mm) (Thermo Finnigan, San Jose, CA, USA) were used for chromatographic separation using 100% 20 mM ammonium acetate (pH 6.8) as Solvent A and 100% acetonitrile as Solvent B. The column temperature was set to 40 °C. The column was equilibrated with 90% Solvent A and 10% Solvent B for 3 minutes and then a linear gradient was run for 7 minutes to 50% Solvent A and 50% Solvent B to achieve separation. The column was then flushed with 50% Solvent A and 50% Solvent B for 2 minutes and re-equilibrated at initial conditions for 7 minutes. A flow rate of 0.2 mL/minute was used and 20 ȝL of sample was injected. Nitrogen was used as sheath gas. The temperature of the heated capillary was 275 °C. Data were analyzed using Thermo Xcalibur Qual Browser 2.1 SP1 programs (Thermo Fisher Scientific Inc., Waltham, MA, USA). Identification and characterization of native MLTELEK and its oxidation products was performed by recording the full mass spectrum (m/z 400-900) in positive ion mode, performing a zoom scan (m/z range = 10) on the most abundant ion and then fragmenting this ion. Fragmentation experiments were performed using helium as collision gas.
Quantification of MLTELEK species by LC/MS
Multiple reaction monitoring (MRM) was set up to monitor the most abundant daughter ion of MLTELEK and its oxidation products, MLTELEK sulfoxide and dehydro-MLTELEK, after fragmentation. Native MLTELEK was detected by fragmenting 863.5 m/z and monitoring the 699.0 m/z fragment ion, MLTELEK sulfoxide was detected by fragmenting 879.5 m/z and monitoring the 815.5 m/z fragment ion, and the dehydro-MLTELEK diastereoisomers were detected by fragmenting 861.5 m/z and monitoring the 473.0 m/z fragment ion. Standard curves were constructed for MRM response against concentration of peptide for all MLTELEK species as described below.
An equal volume of hypochlorous acid (100 ȝM) in PBS was added to native MLTELEK (140 ȝM) in PBS with constant mixing on a vortex and incubated at room temperature for 10 minutes. A 10-fold serial dilution was performed with each dilution being analyzed by LC/MS using MRM. The amount of dehydro-MLTELEK formed was based on the yield that was calculated by utilizing the ability of dehydromethionine to oxidize iodide to triiodide at acidic pH [18] . The amount of MLTELEK sulfoxide formed was based on the concentration of hypochlorous acid added and the assumptions that all of the hypochlorous acid reacts with native MLTELEK and that dehydro-MLTELEK and MLTELEK sulfoxide are the only products formed in this reaction. The detection limits for the dehydro-MLTELEK diastereoisomers, MLTELEK sulfoxide and native MLTELEK were approximately 50, 50 and 400 ϱ fmoles, respectively. The concentrations of MLTELEK and its oxidation products in samples were determined by relating the MRM response to an external standard curve.
Oxidation of calprotectin
For reaction of calprotectin with oxidants, calprotectin (4 ȝM) was treated with hypochlorous acid (0-20 ȝM) in PBS with constant mixing on a vortex and incubated at 37 °C for 10 minutes, or was treated with four additions of hydrogen peroxide (2.5 ȝM) with constant mixing on a vortex at 5 minute intervals in the presence of myeloperoxidase (10 nM) at 37 °C. For inhibition of myeloperoxidase, samples were incubated with 100 ȝM azide or 4-aminobenzoic acid hydrazide (ABAH) at 37 °C for 10 minutes prior to addition of hydrogen peroxide. Trypsin was added to all samples at a 24:1 substrate:trypsin weight ratio and incubated at 37 °C overnight.
Oxidation of extracellular calprotectin by stimulated neutrophils
Neutrophils (5 x 10 6 cells/mL) were incubated in HBSS at 37 °C for 10 minutes in the presence or absence of inhibitors (10 ȝM diphenylene iodonium (DPI), 1 mM azide, 100 ȝM ABAH, 10 ȝM TX1 or 10 ȝM HX1). Calprotectin (2 ȝM) was added immediately prior to stimulation with 100 ng/mL phorbol myristate acetate. After 30 minutes at 37 °C reactions were stopped with the addition of 0.5 ȝg/mL catalase. All samples were centrifuged at 2,000 g for 5 minutes to pellet the neutrophils and the supernatant was collected. Trypsin (50:1 substrate:trypsin weight ratio) was added to the neutrophil supernatant samples and incubated at 37 °C overnight.
Oxidation of intracellular calprotectin by stimulated neutrophils
Neutrophils (5 x 10
6 cells/mL) were incubated in HBSS at 37 °C for 10 minutes in the presence or absence of inhibitors (10 ȝM DPI, 1 mM azide or 100 ȝM ABAH). Reactions were initiated by the addition of opsonized S. aureus (1 x 10 8 cells/mL) and 10% serum. After 30 minutes at 37 °C the cells were pelleted, washed and resuspended in extract buffer before being lysed by nitrogen cavitation (375 psi for 20 minutes on ice). The cytosol was collected after centrifugation (30,000 g) and digested with trypsin (50:1 substrate:trypsin weight ratio) at 37 °C overnight.
Determination of myeloperoxidase in BALF
Myeloperoxidase in BALF from patients with cystic fibrosis was determined using an ELISA as described previously [10] .
Statistics
Statistical analysis was performed using SigmaPlot version 11.0 (Systat Software Inc., San Jose, CA, USA). Analyses for comparisons between groups (cystic fibrosis versus disease controls, or infection versus no infection) were completed using the Mann-Whitney Rank Sum test. Analyses for comparisons between treatments were completed using one-way or two-way ANOVA and Dunnett's post-test (for comparison against control groups) or the Bonferroni post-test (for pairwise analysis). To identify associations between continuous variables a linear regression analysis (Spearman's correlation coefficient) was used. A p value of less than 0.05 was considered significant.
Results
Hypochlorous acid abolishes the nutritional immunity of calprotectin ϲ
To test whether hypochlorous acid affects the nutritional immunity afforded by calprotectin, S. aureus ( Figure 1A) or P. aeruginosa ( Figure 1B) were grown in the presence or absence of the protein.
Calprotectin retarded the growth of both bacteria. Addition of manganese and zinc to the culture media in excess of calprotectin restored bacterial growth. These results are in line with previous work that showed calprotectin limits bacterial growth by chelating manganese and zinc ions [7] . When calprotectin was oxidized by hypochlorous acid, it failed to retard bacterial growth. In fact, calprotectin was exquisitely sensitive to hypochlorous acid. At a molar ratio of one hypochlorous acid per calprotectin, the growthretarding effect of the protein was decreased by 50%. It was completely lost at a ratio of 10:1 ( Figure  1C) . At low doses, the effect of hypochlorous acid was reversed by the reducing agent dithiothreitol (DTT) but at higher doses calprotectin was irreversibly modified by the oxidant (Figure 1D ).
ϳ 
ϴ
The growth of S. aureus (A) and P. aeruginosa (B) was monitored at A 600 over 6 hours in chelex-treated trypticase soy broth supplemented with Ca 2+ , Fe 2+ and Mg 2+ in the presence or absence of calprotectin (100 ȝg/mL, Cal), oxidized calprotectin (treated with 10x hypochlorous acid (HOCl), OxCal) or additional Mn 2+ and Zn 2+ (MZ). The growth of S. aureus was monitored at 6 hours in the presence of calprotectin pre-treated with varying molar ratios of hypochlorous acid (0-10) followed by incubation without (C) or with (D) DTT for 30 minutes at 37 °C. A significant difference (p < 0.05) with the inhibition of growth compared to native calprotectin is indicated by '*', compared to non-oxidized DTTtreated calprotectin is indicated by ' †', and between DTT and non-DTT treated samples with the same molar hypochlorous acid treatment is indicated by '#'. Treated calprotectin was separated by SDS-PAGE in the absence (E) or presence (F) of 100 mM DTT and stained with Coomassie Blue or silver, respectively. All SDS-PAGE gels are representative images from at least three experiments. Values represent the mean ± SD of three-four separate experiments. A8 = S100A8; A9 = S100A9.
Calprotectin is sensitive to modification by hypochlorous acid
To determine how hypochlorous acid modifies the structure of calprotectin, we analyzed the oxidized protein by SDS-PAGE and assessed which tryptic peptides were most easily lost upon treatment. Doses of hypochlorous acid that prevented calprotectin from retarding bacterial growth caused cross-linking of the protein (Figure 1E) . At mole ratios of 1:1 and 2:1 of hypochlorous acid to calprotectin, the S100A9 monomer was sensitive to oxidation and formed a homodimer. This conclusion is supported by the finding that the dominant dimer bands at these doses of oxidant were recognized by anti-S100A9 antibodies in western blot analysis but not by anti-S100A8 antibodies (supplementary data). At higher doses of hypochlorous acid the homodimer was no longer produced. Instead, a dominant dimer corresponding to cross-linked S100A8 and S100A9 was formed ( Figure 1E ). This dimer was recognized by both anti-S100A8 and anti-S100A9 antibodies (data not shown). The homodimer of S100A9 was reducible by DTT, which supports the involvement of a disulfide bond in the cross link ( Figure 1F) . The heterodimer was predominantly converted back to monomers upon reduction but some irreversible crosslinks of calprotectin remained as seen when gels were stained with silver ( Figure 1F ). Thus, a major heterodimer most likely contains a disulfide bridge while the minor form has a non-reducible linkage. To determine which amino acids in calprotectin are modified when it reacts with hypochlorous acid, the protein was digested with trypsin after oxidation. The tryptic peptide most susceptible to change was Nacetyl-TCK, the N-terminal peptide of S100A9 that contains a cysteine residue ( Table 1) . This peptide was almost completely lost at a 2:1 mole ratio of hypochlorous acid to protein. Oxidation of this cysteine residue and the cross-linking of the protein at low doses of hypochlorous acid confirms that S100A9 is readily converted to an intermolecular disulfide. In general, other tryptic peptides that were susceptible to oxidation by hypochlorous acid contained methionine residues ( Table 1) . The most sensitive of these was M93 in the tryptic peptide MHEGDEGPGHHHKPGLGEGTP, which lies between H90 and H94 that are involved in chelating Mn [19, 20] .
The N-terminal methionine on S100A8 is converted to dehydromethionine by hypochlorous acid
To monitor oxidation of calprotectin by hypochlorous acid in vivo, we needed to measure a modification of the protein that is specific to this oxidant. Previously, we showed that hypochlorous acid converts Nterminal methionine residues to dehydromethionine as well as methionine sulfoxide [18] (Figure 2A) . For biological oxidants, formation of dehydromethionine is specific to hypohalous acids. Therefore, we determined whether the N-terminal methionine residue on S100A8 is oxidized to dehydromethionine by hypochlorous acid and can be used as a barometer of the protein's exposure to this oxidant in vivo. Firstly, the N-terminal tryptic peptide, MLTELEK, was reacted with hypochlorous acid and analyzed by LC/MS. Figure 2B) . Fragmentation of the peptide by tandem mass spectrometry (MS/MS) produced partial y-ion (y 2 -y 6 ) and b-ion (b 4 -b 6 ) series matching its predicted fragmentation pattern ( Figure 2C) . Three major product peaks were observed when the peptide was oxidized by hypochlorous acid. They had m/z values of 861.4 (-2), 861.4 (-2) and 879.5 (+16), (Figure 2B ). The peaks with m/z values of 861.4 (2 mass units less than native MLTELEK) had similar fragmentation patterns and produced a partial b-ion series (b 3 -b 6 ), which were all shifted -2 mass units from the native fragmentation pattern (Figure 2D) . The presence of the b 3 ion, corresponding to cleavage of the peptide bond between the threonine and the first glutamic acid, and loss of the four C-terminal residues, indicates that the modification occurs on one of the first three amino acids. The y 6 * ion observed corresponds to the loss of the N-terminal methionine and the additional loss of ammonia as denoted by '*' from the parent ion. The m/z value (715.2) of this ion matches that of the y 6 ion (732.2) observed in the native fragmentation pattern (Figure 2C ) with the additional loss of ammonia (17 mass units) suggesting that the modification occurs on the N-terminal methionine residue. The detection of other y-ions (y 3 ,y 4 ) in the spectrum, which match the m/z values of the native MLTELEK fragments, confirms that the N-terminal methionine residue is modified by -2 mass units. Collectively, these data suggest that the two peaks with m/z values of 861.4 are diastereoisomers of dehydro-MLTELEK.
The peak with an observed m/z value of 879.5 (16 mass units higher than native MLTELEK) ( Figure 2B ) fragmented to one product ion approximately 64 mass units smaller than the parent ion ( Figure 2E ). This fragmentation is characteristic of the loss of methane sulfenic acid (CH 3 SOH) from methionine sulfoxide [21] . Further fragmentation of this product ion gave a sequence consistent with oxidation on the Nterminal methionine residue (data not shown). Next, a multiple reaction monitoring (MRM) method was set up to monitor native MLTELEK and its oxidation products, MLTELEK sulfoxide and dehydro-MLTELEK. MRM involves fragmenting specified parent ions and then specifically monitoring one of their resulting fragments. The most abundant ion from the fragmentation patterns of each of the peptides was monitored. With increasing concentration of hypochlorous acid, the concentration of native MLTELEK decreased and was mirrored by simultaneous increases in the concentrations of MLTELEK sulfoxide and dehydro-MLTELEK (data not shown). The relative concentrations of MLTELEK sulfoxide and dehydro-MLTELEK did not change with changes in the molar ratio of hypochlorous acid to MLTELEK peptide. Dehydro-MLTELEK was quantified based on its ability to oxidize iodide (data not shown) and found to account for 54±4% of the hypochlorous acid added to the MLTELEK peptide ( Table 2 ). The remaining 46±4% was attributed to MLTELEK sulfoxide. The isomers of dehydro-MLTELEK were formed in equal amounts ( Table  2) .
ϭϬ The fragmentation spectrum corresponding to the first eluting (6.6 min) dehydro-MLTELEK diastereoisomer was acquired from the singly-charged ion with an m/z value of 861.4 9 (fragmentation spectrum of second eluting diastereoisomer not shown). (E) The fragmentation spectrum corresponding to MLTELEK sulfoxide was acquired from the singly-charged ion with an m/z value of 879.5 eluting at 3.6 min. Peptide fragments were assigned based on Roepstorff-Fohlman nomenclature [22] . The loss of water from a fragment ion is denoted by '°' where y x° is y x -H 2 O. The loss of ammonia from a fragment ion is denoted by '*' where y x * is y x -NH 3 . Calprotectin (40 ȝM) was treated with hypochlorous acid (0-400 ȝM) in PBS for 10 minutes at room temperature. Samples were digested with trypsin overnight and analyzed using a combination of MALDI TOF MS and LC/ESI-MS. The peak height response (or peak area response for LC/ESI-MS samples) was determined for each peptide and the relative amount of each peptide was calculated as compared to the control sample for each hypochlorous acid concentration. Values represent the mean (±SD) of three separate experiments. A significant difference (p < 0.05) with the amount of peptide present in the control (no added hypochlorous acid) is indicated by bold text. Ac = acetylation.
Once we had demonstrated that the N-terminal tryptic peptide is specifically modified by hypochlorous acid, we investigated whether these modifications also occurred in the whole protein. Calprotectin was reacted with hypochlorous acid, digested with trypsin and analyzed by LC/MS. Similar to the free peptide, the concentration of protein-derived native MLTELEK decreased with increasing concentrations of hypochlorous acid ( Figure 3A) . A simultaneous increase in the concentration of MLTELEK sulfoxide and dehydro-MLTELEK was observed with increasing concentrations of hypochlorous acid and together these products accounted for the loss of native MLTELEK. Both MLTELEK sulfoxide and dehydro-MLTELEK accounted for 13% of the total hypochlorous acid added to the calprotectin. This result suggests that other calprotectin residues were modified. The relative proportions of MLTELEK sulfoxide and dehydro-MLTELEK formed with the whole protein were 74±2% and 26±2%, respectively, which ϭϮ was considerably different from the peptide system as described above ( Table 2) . Approximately twice as much of the early eluting isomer of dehydro-MLTELEK was formed compared to the latter ( Table 2) . This result suggests there may be steric constraints on forming dehydromethionine in the protein compared to the tryptic N-terminal peptide. Collectively, these data establish that dehydromethionine is formed on the N-terminal methionine of S100A8 in intact calprotectin, although at a lower yield than in the free peptide.
To determine whether the N-terminal methionine of S100A8 can be oxidized under more physiological conditions, calprotectin was incubated with myeloperoxidase in the presence of sodium chloride and hydrogen peroxide ( Figure 3B) . A loss of native MLTELEK and an increase in MLTELEK sulfoxide and dehydro-MLTELEK were observed in the full system compared to the control (protein only) and together these products accounted for 24% of the total hydrogen peroxide added. As with reagent hypochlorous acid, approximately twice as much sulfoxide was formed compared to the dehydromethionine containing peptide ( Table 2) . Similarly, twice as much of the early eluting isomer of dehydro-MLTELEK was formed compared to the latter ( Table 2 ). The addition of myeloperoxidase inhibitors azide or 4-aminobenzoic acid hydrazide (ABAH) significantly inhibited the formation of both oxidation products by approximately 75% and 87%, respectively. The absence of hydrogen peroxide from the full system resulted in no formation of MLTELEK sulfoxide or dehydro-MLTELEK (data not shown). With hydrogen peroxide, but no myeloperoxidase, approximately 16% of native MLTELEK was lost (data not shown).
Neutrophils oxidize the N-terminal methionine of calprotectin
To determine whether activated neutrophils can oxidize extracellular calprotectin, the isolated protein was incubated with cells and they were stimulated with phorbol myristate acetate. This soluble stimulus generates extracellular oxidants [23] . The supernatant was collected after centrifugation, digested with trypsin and analyzed by LC/MS using MRM. When neutrophils were stimulated with phorbol myristate acetate ( Figure 3C ) they oxidized the N-terminal methionine of S100A8 to methionine sulfoxide and dehydromethionine. As with reagent hypochlorous acid and myeloperoxidase, approximately twice as much sulfoxide was formed compared to the dehydromethionine containing peptide (Table 2) . Similarly, twice as much of the early eluting isomer of dehydro-MLTELEK was formed compared to the latter ( Table 2) . Pretreatment with the NADPH oxidase inhibitor diphenylene iodonium (DPI) and the myeloperoxidase inhibitors azide, ABAH [24] , HX1 [25], or TX1 [25] significantly inhibited the formation of dehydro-MLTELEK. MLTELEK sulfoxide showed a lesser response to these inhibitors and was not affected by HX1, which is a highly specific inhibitor of myeloperoxidase [25] . These results establish that dehydromethionine is formed on the N-terminal methionine of S100A8 by a system requiring the oxidative burst of neutrophils and myeloperoxidase. However, methionine sulfoxide can be formed independently of myeloperoxidase.
Previous work has shown that intracellular calprotectin is oxidized following stimulation of neutrophils [26] . To determine if MLTELEK sulfoxide and dehydro-MLTELEK are formed on intracellular calprotectin, neutrophils were incubated with opsonized S. aureus. After phagocytosis of the bacteria, the neutrophil cytosol was collected by nitrogen cavitation, digested with trypsin and analyzed by LC/MS using MRM. Phagocytosis of the bacteria resulted in no significant oxidation of the S100A8 N-terminal methionine ( Figure 3D ).
ϭϯ
Figure 3. Detection of MLTELEK species on oxidized calprotectin.
(A) Calprotectin (4 ȝM) was treated with increasing concentrations of hypochlorous acid (0-20 ȝM) in PBS and incubated at 37 °C for 10 minutes. (B) Calprotectin (4 ȝM) was incubated with myeloperoxidase (10 nM) in PBS in the presence or absence of 100 ȝM azide or ABAH at 37 °C for 10 minutes. Reactions were conducted at 37 °C and started by four additions of 2.5 ȝM hydrogen peroxide at 5 minute intervals. The control sample contained calprotectin with no added myeloperoxidase, inhibitors or hydrogen peroxide. (C) Neutrophils were incubated in HBSS at 37 °C in the presence or absence of inhibitors (10 ȝM DPI, 1 mM azide, 100 ȝM ABAH, 10 ȝM TX1 or 10 ȝM HX1). Calprotectin (2 ȝM) was added immediately prior to stimulation. Reactions were initiated by the addition of 100 ng/mL phorbol myristate acetate (PMA). The control sample contained calprotectin with unstimulated neutrophils. After 30 minutes at 37 °C reactions were stopped with the addition of 0.5 ȝg/mL catalase and neutrophils were removed by centrifugation. (D) Neutrophils were incubated in HBSS at 37 °C in the presence or absence of inhibitors (10 ȝM DPI, 1 mM azide or 100 ȝM ABAH). Reactions were initiated by the addition of opsonized S. aureus (1 x 10 8 cells/mL) and 10% serum. The control sample contained neutrophils with no added stimulant or inhibitors. After 30 minutes at 37 °C the cytosol was collected using nitrogen cavitation. Proteins were digested with trypsin before being analyzed by LC/MS using MRM to determine ϭϰ the proportion of each species. Values represent the mean ± SD of three separate experiments. Differences between groups were determined using one-way ANOVA with Dunnett's post-test. A significant difference (p < 0.05) with the concentration of peptide present in the control (no added hypochlorous acid) for (A) or full system for (B-D) is indicated by '*'. CAL = calprotectin; CON = control; FS = full system; AB = ABAH; AZ = azide. a Yields of MLTELEK species were determined using the gradient of the fitted curve in Supplementary Figure 3B where the error represents the standard error of the estimate. HOCl = hypochlorous acid; MPO/H 2 O 2 /Cl -= myeloperoxidase/hydrogen peroxide/chloride system; PMA = phorbol myristate acetate.
Calprotectin is extensively oxidized in the airways of children with cystic fibrosis
When neutrophils are activated by pathogenic bacteria in the airways of children with cystic fibrosis, they release substantial amounts of calprotectin, myeloperoxidase, and hypochlorous acid [8, 10, 27 ]. Consequently, it is possible that some of the calprotectin is oxidized by hypochlorous acid. To test this possibility, we measured the degree of oxidation of the N-terminal tryptic peptide of S100A8 in bronchoalveolar samples from children with cystic fibrosis and disease controls. Native MLTELEK and both its oxidation products, MLTELEK sulfoxide and dehydro-MLTELEK, were detected in bronchoalveolar lavage fluid (BALF) as determined by MRM mass spectrometry ( Figure 4A) . To validate the presence of the MLTELEK species, the ions corresponding to the singly-charged species of native MLTELEK, dehydro-MLTELEK and MLTELEK sulfoxide were subjected to fragmentation by MS/MS in one of the samples (Figure 4B-D) . The fragmentation patterns observed were similar to those obtained when calprotectin or the native peptide were treated with hypochlorous acid (Figure 2C-E) . These results confirm the presence of native MLTELEK and its oxidation products in BALF from children with cystic fibrosis. No chlorinated peptides were detectable in BALF. A significant correlation (r=0.93; p < 0.0001) was found between MLTELEK sulfoxide and dehydro-MLTELEK concentration ( Figure 4E ). This strong correlation suggests that both species were formed by the same oxidant, presumably hypochlorous acid. The relative proportions (±SD) of native MLTELEK, MLTELEK sulfoxide and dehydro-MLTELEK in samples containing more than 20 nM of total measured MLTELEK (n = 11) were 6±3%, 86±6% and 8±3%, respectively ( Figure 4F) . These results indicate that calprotectin in BALF was predominantly oxidized. Interestingly, the early eluting isomer of dehydro-MLTELEK was formed almost exclusively suggesting that the latter isomer is much less stable under physiological conditions ( Table 2) . MLTELEK and its oxidized forms were all strongly associated with the concentration of myeloperoxidase in BALF (r > 0.086; r < 0.0001 n= 18).
ϭϱ ϭϲ Figure 4 . Detection of MLTELEK species in BALF from children with cystic fibrosis. BALF samples from children with cystic fibrosis (n=18) were digested with trypsin before being analyzed by LC/MS using MRM to detect native MLTELEK and its oxidation products. (A) The individual panels represent the MRM chromatograms for each MLTELEK species from a representative sample. The ions with m/z values corresponding to the singly-charged (B) native MLTELEK, (C) dehydro-MLTELEK and (D) MLTELEK sulfoxide species were subjected to fragmentation by MS/MS to confirm their identities. The acquired fragmentation spectra were similar to that observed with the native peptide treated with hypochlorous acid (Figure 2C-E) . Peptide fragments were assigned based on Roepstorff-Fohlman nomenclature [22] . The loss of water from a fragment ion is denoted by '°' where y x° is y x -H 2 O. The loss of ammonia from a fragment ion is denoted by '*' where y x * is y x -NH 3 . (E) A significant association (p < 0.05) was determined between the concentrations of MLTELEK sulfoxide and dehydro-MLTELEK. r s = Spearman's rank correlation coefficient. (F) The relative proportions of MLTELEK and its oxidation products in BALF samples from children with cystic fibrosis containing more than 20 nM of total measured MLTELEK (n = 11).
The concentrations of dehydro-MLTELEK and MLTELEK sulfoxide were significantly higher in BALF from children with cystic fibrosis (n = 18) than disease controls (n = 10) ( Figure 5A-B) . There was no significant difference observed in the concentration of native MLTELEK between the two groups (data not shown). To assess whether infections lead to greater formation of oxidized calprotectin, BALF samples were cultured for organisms that colonize the lower airways in children with cystic fibrosis. Cultures with any growth detected were considered positive. Of the 18 samples analyzed, 7 returned positive cultures. BALF with positive cultures had significantly elevated concentrations of dehydro-MLTELEK, MLTELEK sulfoxide and native MLTELEK ( Figure 5C-E) . Furthermore, approximately 90% of the N-terminal tryptic peptide of calprotectin was oxidized. The concentrations of dehydro-MLTELEK (r=0.54, p=0.021) ( Figure 5F ) and native MLTELEK (r= 0.48, p = 0.043) but not MLTELEK sulfoxide were significantly associated with the number of bacteria present in the BALF samples. Collectively, these data demonstrate that when neutrophils respond to infections in the airways of children with cystic fibrosis, they release calprotectin and oxidize most of it with hypochlorous acid.
Discussion
In this investigation we found that the bacteriostatic properties of calprotectin are lost when it is oxidized by hypochlorous acid. Low doses of this strong neutrophil oxidant were sufficient to incapacitate calprotectin by cross-linking S100A8 and S100A9, and oxidizing their methionine residues. We have also demonstrated that almost all of S100A8 in the airways of children with cystic fibrosis had its N-terminal residue oxidized. At these levels of oxidation, calprotectin would be unable to provide nutritional immunity by sequestering Mn and Zn ions. Consequently, calprotectin released by activated neutrophils in the airways of children with cystic fibrosis is unlikely to combat infections. Our findings suggest that strategies aimed at preventing oxidation of calprotectin may bolster innate immunity in cystic fibrosis as well as combat oxidative stress. This conclusion is bolstered by the finding that calprotectin is present in a large excess over zinc and manganese ions in adult sputum [28] . Hence, substantial oxidation of calprotectin could make these ions available to bacteria for their growth.
ϭϳ Recent studies have demonstrated that calprotectin is a critical factor in the innate immune response to infection because it can chelate Mn and Zn ions and thereby starve bacteria of these essential ions [7] . Chelation of Mn occurs at the dimer interface of S100A8 and S100A9 where six histidine residues are suitably orientated to bind the metal with high affinity [19, 20] (Figure 6 ). Oxidation of calprotectin by hypochlorous acid would disrupt this favorable alignment. In particular, the rapid oxidation of the Nterminal cysteine residue on S100A9 to promote dimers of this monomer would eliminate the metal binding site. The metal binding site would also be disturbed by oxidation of M93, which is the most susceptible methionine residue to oxidation. It lies between H90 and H94, two residues that are critical to the hexadentate chelating site (Figure 6 ). Oxidation of hydrophobic methionine to hydrophilic methionine sulfoxide is known to flip this residue to the surface of proteins, turning them inside out [29] . Consequently, the chelating properties of calprotectin are expected to be weakened when its cysteine and methionine residues are oxidized. Figure 6 . Crystal structure of Mn-bound calprotectin. S100A8 (green) and S100A9 (turquoise) together form the calprotectin heterodimer. The Mn ion (purple sphere) is chelated by six histidine residues (H17 and H27 from S100A8, and H90, H94, H102 and H104 from S100A9). Methionine and cysteine residues determined to be susceptible to oxidation by hypochlorous acid (Table 1 ) are labelled. Image produced using PyMOL and Protein Data Bank ID: 4GGF. The mutated Ser42 on S100A8 was replaced with the original cysteine. Thr1 and Cys2 were manually added to the S100A9 N-terminal as these data were not available. S100A8 and S100A9 from mice and humans have previously been shown to be susceptible to oxidation by hypochlorous acid [30] . Here we report similar modifications to the individual monomers to those ϭϵ described in the earlier studies. This includes the formation of irreversible cross links that are most likely sulfinamide and sulfilimine bonds between lysine residues and cysteine or methionine residues, respectively [30, 31] . In contrast to our work, it was recently suggested that hypochlorous acid has little effect on preformed calprotectin [32] . However, it is apparent that calprotectin is susceptible to oxidation by hypochlorous acid with the terminal cysteine on S100A9 being the most sensitive residue, followed by the cysteine residue on S100A8, and methionine residues on both chains. We also demonstrated for the first time that the N-terminal methionine of S100A8 is readily oxidized by hypochlorous acid. As expected, this methionine was converted to methionine sulfoxide. However, dehydromethionine was also a substantial product. The presence of this cyclic azasulfonium cation (Figure 2A ) on the N-terminal tryptic peptide of S100A8 gives the protein a post-translational modification that can be attributed to hypochlorous acid. In contrast, methionine sulfoxide is formed by a range of oxidants. Consequently, dehydromethionine on the N-terminal peptide of S100A8 can be used as a biomarker of hypochlorous acid. Also, given that this methionine residue was lost after the cysteine residues and M93, its oxidation should signify a loss in the metal chelating ability of calprotectin.
Based on our findings, mild oxidation of calprotectin involving the N-terminal cysteine residue on S100A9 would be expected to be a reversible post-translation modification of the protein. This could result in either S100A9 cross links or S-glutathionylation of the N-terminal cysteine residue [26] . However, once the methionine residues and other cysteine residues are oxidized it is apparent that the nutritional immunity afforded by calprotectin would not be recoverable. Calprotectin has also been reported to modulate NADPH oxidase activity [33] [34] [35] , influence neutrophil migration [36] [37] [38] , and regulate neutrophil number and apoptosis [39] . Oxidation of Met62 and Met82, but not Met80, removes the chemo-repulsive effect of S100A9 on neutrophils [37] , and is speculated to play a role in the antifungal effect of calprotectin on Candida albicans [40] . The S100A8 N-terminal peptide, MLTELEKALNSIID, which is present in pancreatic cancer tissue, impairs glucose metabolism, and this effect is lost upon oxidation [41] . Other functions of calprotectin may similarly be altered in vivo by oxidation of its cysteine and methionine residues. In particular, the facile oxidation of the N-terminal cysteine residue on S100A9 has been suggested to act as a redox switch for the functions of calprotectin [30] . Further research into the cross-linking or S-glutathionylation of this residue is likely to reveal how this redox switch modulates the physiological functions of S100A9 and calprotectin.
Once we had developed a sensitive and specific mass spectrometry method for detecting the N-terminal tryptic peptide of S100A8 and its oxidized forms, it was possible to demonstrate that myeloperoxidase and stimulated neutrophils also form these products. Neutrophils readily oxidized extracellular calprotectin using myeloperoxidase, as demonstrated by using specific inhibitors of the enzyme. Calprotectin was also oxidized within neutrophils but only when they were activated with soluble stimuli. There was no detectable hypochlorous acid-dependent oxidation of calprotectin when neutrophils phagocytosed bacteria. This is expected because within phagosomes, where bacteria are trapped, hypochlorous acid reacts rapidly with proteins and is unlikely to diffuse into the cytosol [42] . However, in recent work we have found that calprotectin within neutrophils is carbonylated on S100A9 by lipid oxidation products formed when neutrophils ingest bacteria [43] .
Previously, we tracked the characteristic footprints hypochlorous acid leaves when it reacts with biomolecules [44] to show that substantial amounts of this oxidant are produced in the airways of children with cystic fibrosis [10, 27, 45] . Therefore, we expected to find oxidized calprotectin in BALF. However, it was surprising that virtually all the N-terminal tryptic peptide of S100A8 was oxidized. This finding indicates that most of the airway calprotectin had been oxidized and substantially modified. The strong association of myeloperoxidase with MLTELEK and its oxidized forms in BALF supports the proposal that calprotectin was derived from neutrophils and that these inflammatory cells were also promoted its oxidation. Indeed the equally strong correlation between methionine sulfoxide and dehydro-methionine on S100A8 suggested that hypochlorous acid was largely responsible for oxidation. Other oxidants such ϮϬ as peroxynitrite and singlet oxygen may also contribute to formation of dehydro-MLTELEK but given the large amounts of hypochlorous acid produced in the airways of children with cystic fibrosis, their contribution is likely to be minor. Importantly, the extent of oxidation of the N-terminal of S100A8 means that essentially all of the calprotectin in BALF would be incapable of chelating Mn and Zn. Consequently, calprotectin should not be expected to provide nutritional immunity in cystic fibrosis. Besides metal chelation, other immune functions of calprotectin, and its individual monomers, are also likely to be affected by its oxidation in the airways. Future work needs to be focused on the ability of calprotectin to limit growth of bacteria in biofilms because it is relevant to infections in adult cystic fibrosis where viscous and metal-rich-tracheobronchial secretions of thiol-rich glycolproteins are produced.
Inhibition of extracellular myeloperoxidase is a potential strategy for limiting oxidative stress in the airways and maintaining the immune functions of calprotectin. Several selective inhibitors of myeloperoxidase are now available and should be tested in animal models of cystic fibrosis [25, 46] . Inhibitors that targeted only extracellular myeloperoxidase would be an advantage because they should block oxidative stress without compromising host defense. Their development would provide a new and complementary treatment for the debilitating lung disease in cystic fibrosis.
